BNP Paribas Corporate Governance April 2024
CORPORATE GOVERNANCE
Jean LEMIERRE
Chairman
Disclaimer
The figures included in this presentation are unaudited.
As a reminder, on
This presentation includes forward-looking statements based on current beliefs and expectations about future events. Forward-looking statements include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives and expectations with respect to future events, operations, products and services, and statements regarding future performance and synergies. Forward-looking statements are not guarantees of future performance and are subject to inherent risks, uncertainties and assumptions about
The information contained in this presentation as it relates to parties other than
The sum of values contained in the tables and analyses may differ slightly from the total reported due to rounding. The alternative performance measures are defined in the press release published jointly with this presentation.
2
The BNP Paribas Fundamentals
Corporate Governance within BNP Paribas The Board of Directors and its Committees Corporate Officers' Compensation
Appendix
182,657 employees in 63 countries*
58,126 excluding domestic markets
4,846
488
4,263
5,661
21,348
55,710
15,931
LUXEMBOURG
3,552
12,732
80% of staff in
* Figures as at
|
Corporate Governance - |
4 |
Client-centric
A long-term approach strengthened by
solid risk management
Integrated
Full coverage of client needs, with
leading franchises in
- A resilient, growth- generating model
Net Income1 (€)
- 49.2%
CAGR 2018-23: +8.3%
2018 2019 2020 2021 2022 2023
- A balanced allocation of capital
|
CIB |
Commercial & |
|
|
~1/3 Personal |
||
|
~1/3 |
|
~1/3 |
Banking |
|
Specialised |
|
|
Businesses |
Diversified
Across customer segments, regions,
sectors and business lines
At scale
Strengthened execution via industrialisation and new technologies
- Continuous efficiency gains
Cost/income ratio2
67,3% 66,5%
68,9% 64,7%
66,7%61,6%
2018 2019 2020 2021 2022 2023
- An enhanced risk profile
|
Cost of risk / GOI2 |
|||||
|
21,6%22,1% |
38,6%3 |
||||
|
20,2%17,4% |
|||||
|
16,1% |
|||||
|
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
1. Proforma 2022
Application of IFRS 17 and IFRS 5 effective 2022; 3. Note: €1.4bn in stage 1 & 2 provisions related to the public health crisis of 2020
Corporate Governance -
Structural improvement in the risk profile over the past 10 years
Cost of risk1 supported by a prudent risk profile
In bps / customer loans outstanding
|
Guidance |
|||||||||||
|
66 |
2022-2025 |
||||||||||
|
57 |
<40 |
||||||||||
|
54 |
|||||||||||
|
46 |
39 |
||||||||||
|
39 |
35 |
34 |
34 |
32 |
|||||||
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Stages 1 & 2 provisions in 2020
Prudent growth of market activities: stable VaR
(a measure of market risk)
|
6.8 |
8.0 Annual Global |
||||||||||||||
|
Markets revenues |
|||||||||||||||
|
5.7 |
(€bn) |
||||||||||||||
|
5.4 |
4.7 |
||||||||||||||
|
39 |
45 |
38 |
|||||||||||||
|
32 |
34 |
34 |
28 |
||||||||||||
|
26 |
25 |
24 |
Average annual
VaR (99%,1 day)
In €m
- Cost of risk1: €2,907m (-€96m vs. 2022)
-
- Cost of risk still at a low level, below 40 bps
- Provisions on non-performing loans (stage 3) of €1,833m, excluding Personal Finance
- Release of €517m in provisions on performing loans (stages 1 & 2), including an additional provision of €158m on the commercial real-estate portfolio
- High stock of stage 1 & 2 provisions: €5.0bn
1. Note: the cost of risk does not include "Other net losses for risk on financial instruments", i.e., losses related to risk of invalidation or non-enforceability of financial instruments granted (extraordinary provisions on mortgage loans in
Corporate Governance -
€704bn as at
|
€bn |
|
|
||
|
Credit risk |
535 |
580 |
||
|
Operational Risk |
59 |
62 |
||
|
Counterparty Risk |
45 |
42 |
||
|
Market vs. Foreign exchange Risk |
29 |
26 |
||
|
Securitisation positions in the banking book |
17 |
16 |
||
|
Others2 |
19 |
20 |
||
|
|
704 |
745 |
|
Corporate |
||
|
Centre |
||
|
IPS |
Specialised |
|
|
Businesses |
||
|
6% |
||
|
(CPBS) |
||
|
6% |
18% |
|
|
34% |
Commercial & |
|
|
Personal |
||
|
36% |
||
|
CIB |
Banking |
|
|
(CPBS) |
||
|
Corporate |
|
|
Centre: 6% |
Personal Finance: 12% |
|
IPS: 6% |
|
|
Arval & Leasing |
|
|
Global Markets & |
Solutions: 5% |
|
Securities Services: |
|
|
14% |
CPBF: 14% |
|
Global Banking: |
BNL bc: 6% |
|
20% |
CPBB: 8% |
|
NDB & PI3: 1% |
CPBL: 1% |
Europe Med.: 7%
1. CRD5; 2. Including the DTAs and significant investments in entities in the financial sector subject to 250% weighting ; 3. New Digital Businesses &
|
Corporate Governance - |
7 |
Tangible net book value per share1
|
€ |
||
|
CAGR |
||
|
+6.9% |
87,6 |
|
|
73,2 |
78,7 |
79,3 |
|
63,3 |
||
|
52,4 |
||
|
32,0 |
+10% |
|
|
vs. 2022 |
||
|
2008 2012 2016 2020 2021 2022 2023 |
Earnings per share2
|
€ |
|||
|
CAGR |
9,2 |
||
|
+7.6% |
|||
|
7,8 |
|||
|
7,3 |
|||
|
5,2 |
6,0 |
5,3 |
|
|
3,1 |
+18% |
||
|
vs. 2022 |
|||
|
2008 2012 2016 2020 2021 2022 2023 |
Cash dividend per
share4
|
€ |
||
|
CAGR |
4,60 |
|
|
+10.9% |
||
|
3,90 |
||
|
3,67 |
||
|
2,70 |
2,66 |
|
|
1,50 |
+18% |
|
|
vs. 2022 |
||
|
0,97 |
||
|
2008 2012 2016 2020 2021 2022 2023 |
Total RetuPerformance (incl. gross dividend) - Base
120
100
80
60
40
20
0
In relative terms compared
to
+250%
+97%
Payout ratio of 60%3
- 2023 cash dividend:€4.60per share4
- Share buyback programme5: €1.05bn planned for 20245
|
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
|
|
Euro STOXX Banks (rebased) |
|||||||||||
1. Revalued at the end of period, in €; 2. 2023 earnings per share calculated on the basis of 2023 distributable Net Income and the number of shares outstanding at end of period (€8.79 based on average number of shares); 3. Applied to distributable Net Income after TSSDI; 4. Subject to approval by the General Meeting of
5. Upon customary conditions precedents (including
Corporate Governance -
The BNP Paribas Fundamentals
Corporate Governance within
The Board of Directors and its Committees
Corporate Officers' Compensation
Appendix
A Corporate Governance Framework Deeply Embedded in
the Bank's Culture
A « Triptic » Culture / Governance / Business Strategy
Balance, stability and consistency of the strategy
A culture of control and risk management, aiming at helping customers to implement their projects
A risk-reward balance closely monitored throughout the cycle
A commitment for a positive impact on society as a whole
Business model is closely aligned with culture, focused on:
- Customers (vs sales)
- Long term (vs short term) results
- Sustainability (vs growth)
- Efficiency (vs low cost)
A reputation based on rigorous rules of ethics, compliance and transparency and on a true social commitment: focus on
- Values, compliance, behaviour
- Consistency of message
- Tone at the top......Echo from the bottom
Corporate Governance -
Attachments
Disclaimer
BNP Paribas SA published this content on



California State Senate Health Committee Unanimously Passes Legislation to Save California $175 Million Annually
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Globe Life Inc. (GL) Investors
Advisor News
- SEC manual shake-up: What every insurance advisor needs to know now
- Retirement moves to make before April 15
- Millennials are inheriting billions and they want to know what to do with it
- What Trump Accounts reveal about time and long-term wealth
- Wellmark still worries over lowered projections of Iowa tax hike
More Advisor NewsAnnuity News
- Variable annuity sales surge as market confidence remains high, Wink finds
- New Allianz Life Annuity Offers Added Flexibility in Income Benefits
- How to elevate annuity discussions during tax season
- Life Insurance and Annuity Providers Score High Marks from Financial Pros, but Lag on User Friendliness, JD Power Finds
- An Application for the Trademark “TACTICAL WEIGHTING” Has Been Filed by Great-West Life & Annuity Insurance Company: Great-West Life & Annuity Insurance Company
More Annuity NewsHealth/Employee Benefits News
- Younger generations experience serious health issues earlier in life
- REP. GABE VASQUEZ CHAMPIONS BILL TO CAP PRESCRIPTION DRUG PRICES FOR NEW MEXICANS
- Medicaid and CHIP reliance by state: 2026 study
- NC State Health Plan won’t extend Aetna or CVS contracts, will seek bids instead
- Trump's Medicaid work mandate could kick thousands of homeless Californians off coverage
More Health/Employee Benefits NewsLife Insurance News
- Best’s Special Report: US Life/Health Insurance Industry Sees Impairments Halved in 2024
- Jackson Study Exposes Stark Disconnect Between Anticipation of Policy Change and Retirement Planning Conversations
- Thrivent plans to add 600 advisors this year
- Third Federal Named a top Financial Services Company by USA TODAY
- New Allianz Life Annuity Offers Added Flexibility in Income Benefits
More Life Insurance News